Epigenetics: Principles and practice

Digestive Diseases

Volumn 29, Issue 2, 2011, Pages 130-135

  Hamilton, James P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epigenetics; Histone modifications; Hypermethylation; Hypomethylation; Loss of imprinting; MicroRNA

Indexed keywords

DNA FRAGMENT; HISTONE; POLYCLONAL ANTIBODY; UNTRANSLATED RNA;

ALLELE; AUTISM; BARRETT ESOPHAGUS; BECKWITH WIEDEMANN SYNDROME; BIPOLAR DISORDER; CANCER CELL CULTURE; CANCER DIAGNOSIS; CARCINOGENESIS; CHROMATIN; CHROMOSOME STRUCTURE; COLON CANCER; CONFERENCE PAPER; DIET; DNA METHYLATION; DNA MODIFICATION; DNA REPAIR; DNA REPLICATION; DNA SEQUENCE; ENTERITIS; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GASTROINTESTINAL DISEASE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GENOME IMPRINTING; GILLES DE LA TOURETTE SYNDROME; HAPPY PUPPET SYNDROME; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; HUMAN; IMMUNOPRECIPITATION; ISOSCHIZOMER; LIFESTYLE; LIFESTYLE MODIFICATION; LIVER CIRRHOSIS; MASS SPECTROMETER; MITOTIC RECOMBINATION; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; RNA SEQUENCE; RNA TRANSLATION; SCHIZOPHRENIA; TREATMENT RESPONSE;

ANIMALS; CHROMATIN; DNA METHYLATION; ENVIRONMENT; EPIGENESIS, GENETIC; GENOMIC IMPRINTING; HUMANS; RNA, UNTRANSLATED;

EID: 79960144202     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000323874     Document Type: Conference Paper

References (23)

1. Gibney ER, Nolan CM: Epigenetics and gene expression. Heredity 2010; 105: 4-13.
2. Jirtle RL, Skinner MK: Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007; 8: 253-262. (Pubitemid 46439287)
3. Feinberg AP: Epigenetics at the epicenter of modern medicine. JAMA 2008; 299: 1345-1350. (Pubitemid 351439080)
4. Esteller M: Epigenetics in cancer. N Engl J Med 2008; 358: 1148-1159.
5. Selaru FM, David S, Meltzer SJ, Hamilton JP: Epigenetic events in gastrointestinal cancer. Am J Gastroenterol 2009; 104: 1910-1912.
6. Feinberg AP, Vogelstein B: Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89-92. (Pubitemid 13154475)
7. Calvisi DF, Ladu S, Gorden A, Farina M, Lee JS, Conner EA, et al: Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 2007; 117: 2713-2722. (Pubitemid 47494371)
8. Roberts LR, Gores GJ: Hepatocellular carcinoma: molecular pathways and new therapeutic targets. Semin Liver Dis 2005; 25: 212-225. (Pubitemid 40781073)
9. Lee HS, Kim BH, Cho NY, Yoo EJ, Choi M, Shin SH, et al: Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma. Clin Cancer Res 2009; 15: 812-820.
10. Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042-2054. (Pubitemid 37448928)
11. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826. (Pubitemid 26296693)
12. Dupont JM, Tost J, Jammes H, Gut IG: De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal Biochem 2004; 333: 119-127. (Pubitemid 39209229)
13. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, et al: Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005; 37: 853-862. (Pubitemid 41077111)
14. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, et al: Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999; 59: 2307-2312. (Pubitemid 29242273)
15. Hamilton JP: Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies. Epigenomics 2010; 2: 233-243.
16. Esteller M: Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8: 286-298. (Pubitemid 46439286)
17. Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, Meltzer SJ, et al: Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010; 16: 1729-1738.
18. Olaru AV, Selaru FM, Mori Y, Vazquez C, David S, Paun B, et al: Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflamm Bowel Dis 2011; 17: 221-231.
19. Selaru FM, Olaru AV, Kan T, David S, Cheng Y, Mori Y, et al: MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 2009; 49: 1595-1601.
20. Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y, et al: The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009; 136: 1689-1700.
21. Boland CR, Shin SK, Goel A: Promoter methylation in the genesis of gastrointestinal cancer. Yonsei Med J 2009; 50: 309-321.
22. Hamilton JP, Sato F, Greenwald BD, Suntharalingam M, Krasna MJ, Edelman MJ, et al: Promoter methylation and response to chemotherapy and radiation in esophageal cancer. Clin Gastroenterol Hepatol 2006; 4: 701-708. (Pubitemid 43825806)
23. Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, et al: A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res 2009; 69: 4112-4115.